Human Longevity, Inc.
Author: Michael
HCW Biologics Inc., a U.S.
Serina Therapeutics announced that feedback from
Jupiter Neurosciences has launched a new Nugevia
Nanoscope Therapeutics presented three-year follo
ARDD presentation addresses the need for consens
A form of interval walking training, known as R
Cellular reprogramming research collab with Retr
Lighthouse Pharmaceuticals received a $49.
Lighthouse Pharma lands major grant funding to a